AFMD Affimed N.V.

2.30
-0.05  -2%
Previous Close 2.35
Open 2.30
Price To book 1.85
Market Cap 101.06M
Shares 43,938,000
Volume 95,198
Short Ratio 2.96
Av. Daily Volume 287,047

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1b update 2H 2017.
AFM13 with Keytruda
Hodgkin Lymphoma - Cancer
Phase 2a update due 2H 2017 with full data due 2019.
AFM13
Hodgkin Lymphoma - Cancer